A prospective non-randomized controlled study on the treatment of interstitial pneumonia of RA with Peitushengjinjiedutongluo method
Not Applicable
- Conditions
- Rheumatoid arthritis with interstitial pneumonia
- Registration Number
- ITMCTR2100005066
- Lead Sponsor
- Zhejiang Chinese Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Comply with 2010 ACR/EULAR RA classification standard and RA-ILD (UIP type) diagnosis;
2. 5.1> DAS28 >2.6;
3. Course of disease> 24 months;
4. Aged from 18 to 65 years;
5. The patient informed and agreed to participate in the study.
Exclusion Criteria
1. Those who have used DMARDs other than hydroxychloroquine and glucocorticoids within 2 months;
2. Patients with other severe organ disease or mental illness;
3. Those who are allergic to the drugs involved in the research protocol or have contraindications.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Carbon monoxide dispersion capacity;Forced vital capacity;ILD score on HRCT scan;
- Secondary Outcome Measures
Name Time Method Overall assessment of the patient's own condition PGA;Functional Assessment of Treatment of Chronic Diseases-Fatigue;Doctor's overall assessment of the patient's condition MDGA;Clinical disease activity index score;Simplified disease activity index score;Rheumatoid arthritis disease activity evaluation index DAS28;Health Assessment Questionnaire Disability Index HAQ-DI;